Navigation Links
Heart-Pacing Devices Hold Promise for Heart Failure

Defibrillators, pacemakers offer benefits for patients with milder forms of the condition, study suggests

THURSDAY, Oct. 1 (HealthDay News) -- New research provides more evidence that a new type of pacemaker/defibrillator technology may be a good option for patients with mild forms of heart failure.

An international team of researchers reports that the kind of heart "pacing" provided by new defibrillators and pacemakers can help these patients. But the research still needs to be confirmed before doctors begin embracing its findings, said a cardiologist familiar with the research.

The technology in question "is expensive, resource-intensive, and associated with increased risk of complications compared with less complex devices," explained Dr. Jeptha Curtis, an assistant professor of medicine at the Yale University School of Medicine.

Heart failure occurs when the heart fails to pump blood properly, often as a result of heart attacks, and affects an estimated 5.7 million Americans. "Patients often feel fatigue, as well as shortness of breath from fluid building up in the lungs and swelling of the legs from fluid building up there as well," said Dr. Kevin Heist, a cardiac electrophysiologist at Massachusetts General Hospital.

Cardiac resynchronization therapy defibrillators, which shock the heart to return it to a normal rhythm, are used in some patients with advanced cases of heart failure. Pacemakers are also available with the technology, Heist said.

The devices control the left and right sides of the heart, which can improve heart failure symptoms like shortness of breath and fatigue, Heist said.

The new study, published online Sept. 30 in the Journal of the American College of Cardiology, looked at whether the kind of heart control used in some new defibrillators -- known as biventricular pacing -- would work in patients with milder cases of heart failure.

The researchers randomly assigned 262 patients with defibrillators or pacemakers to receive normal treatment with the devices or to have an extra "pacing" function turned on to help their hearts beat more properly. The patients who got the more expanded treatment did better and lived longer.

"However, the study is definitely not definitive, and we will need to see the results of similar, ongoing trials before we change practice," Curtis said.

One problem is that the research is part of a larger study that hasn't shown such a dramatic improvement in patients due to the technology, Curtis said.

"The reasons of this discrepancy are not clear, but it makes it that much more important that the results be confirmed before we start using this technology more aggressively," he said.

Heist, however, said another study came up with similar results.

Overall, only about 20 percent of patients whose lives may be improved by defibrillators actually get them, Heist said. "This is due to a combination of patient reluctance and lack of knowledge by referring physicians," he said. "Many lives could be saved if this rate could be improved."

More information

For more about heart failure, visit the American Heart Association.

SOURCES: Jeptha Curtis, M.D., assistant professor, medicine, Yale University School of Medicine, New Haven, Conn.; Kevin Heist, M.D., Ph.D., cardiac electrophysiologist, Massachusetts General Hospital, Boston; Sept. 30, 2009, Journal of the American College of Cardiology, online

Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New AnyTrack GPS Devices Track Assets Indoors, Outdoors or Hidden
2. Design Resource Extends Support for Orthopaedic and Cardiovascular Devices
3. FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
4. HealthShares(TM) Announces Change to the HealthShares(TM) Cardio Devices Index
5. Nationwide independent Taser study results suggest devices are safe
6. Brain measurements could lead to better devices to move injured or artificial limbs
7. Do women fare worse with some heart devices?
8. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cardio Devices, and the HealthShares(TM) Orthopedic Repair Indexes
9. DeviceSpace Career Fair Opens Doors for Hundreds of Medical Device and Diagnostics Career Candidates
10. Hazardous Advanced Micro Devices (A.M.D.) Clean Room Chemicals Caused Multiple Birth Defects, Lawsuit Alleges
11. SPO Medical Unveils New Oximetry Devices for European Markets
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology: